drugset / Trial / NCT00640926
Safety and Efficacy Study of Oxazolidinone to Treat Pneumonia
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to determine whether RX-1741, an oxazolidinone antibiotic, is safe and effective in the treatment of mild to moderate community acquired pneumonia (CAP).
Timeline
- Start
- 2007-10
- Primary completion
- 2009-03
- Completion
- 2009-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Radezolid | Small molecule | 300 mg | Oral |
| Subject | Radezolid | Small molecule | 450 mg | Oral |
| Subject | Radezolid | Small molecule | 900 mg | Oral |